Literature DB >> 20154293

Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometrician.

Michael Neely1, Roger Jelliffe.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20154293     DOI： 10.1177/0091270009356572

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  20 in total

1.  In silico children and the glass mouse model: clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis.

Authors:  Prakash M Jeena; William R Bishai; Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

2.  Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R.

Authors:  Michael N Neely; Michael G van Guilder; Walter M Yamada; Alan Schumitzky; Roger W Jelliffe
Journal:  Ther Drug Monit       Date:  2012-08       Impact factor: 3.681

3.  Are vancomycin trough concentrations adequate for optimal dosing?

Authors:  Michael N Neely; Gilmer Youn; Brenda Jones; Roger W Jelliffe; George L Drusano; Keith A Rodvold; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

Review 4.  Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.

Authors:  Michael N Neely; Natella Y Rakhmanina
Journal:  Clin Pharmacokinet       Date:  2011-03       Impact factor: 6.447

5.  Reversing the myths obstructing the determination of optimal age- and disease-based drug dosing in pediatrics.

Authors:  Michael D Reed
Journal:  J Pediatr Pharmacol Ther       Date:  2011-01

Review 6.  Opportunities for model-based precision dosing in the treatment of sickle cell anemia.

Authors:  Min Dong; Tomoyuki Mizuno; Alexander A Vinks
Journal:  Blood Cells Mol Dis       Date:  2017-08-09       Impact factor: 3.039

Review 7.  Pharmacokinetic modeling of therapies for systemic lupus erythematosus.

Authors:  Xiaoyan Yang; Catherine M T Sherwin; Tian Yu; Venkata K Yellepeddi; Hermine I Brunner; Alexander A Vinks
Journal:  Expert Rev Clin Pharmacol       Date:  2015-07-09       Impact factor: 5.045

Review 8.  Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatrics.

Authors:  Kevin J Downes; Andrea Hahn; Jason Wiles; Joshua D Courter; Alexander A Vinks
Journal:  Int J Antimicrob Agents       Date:  2013-12-17       Impact factor: 5.283

Review 9.  Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.

Authors:  Jeannine S McCune; Meagan J Bemer; Janel Long-Boyle
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447

10.  Variation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipients.

Authors:  Jeannine S McCune; K Scott Baker; David K Blough; Alan Gamis; Meagan J Bemer; Megan C Kelton-Rehkopf; Laura Winter; Jeffrey S Barrett
Journal:  J Clin Pharmacol       Date:  2013-01-24       Impact factor: 3.126
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.